Kyinno Bio, USA  

Kyinno Bio, headquartered in the United States, is a biotechnology company specializing in antibody discovery and engineering technologies. The company has built an extensive portfolio that includes more than 3,000 genetically engineered cell lines, bispecific and trispecific antibody discovery mouse models, and over 5,000 antibody-specific MPSA-AB5000 screening panels. In addition, Kyinno Bio integrates its proprietary KY-AI™ artificial intelligence platform to accelerate and optimize antibody development workflows.